Lifestyle support may boost IBD treatment success

NCT ID NCT07168499

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 37 times

Summary

This study tests whether adding diet counseling and stress management to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis achieve remission. About 160 adults will be split into four groups, each receiving different combinations of dietitian and psychologist visits. The main goal is to see if these lifestyle add-ons improve symptoms after 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

diet management and stress management

What this could lead to

If it works, this could show that adding lifestyle support to standard IBD treatment helps more people achieve remission.

What could go wrong

This is a small, early-stage trial with only 160 participants, so results may not apply to everyone. The lifestyle interventions are brief and may not be enough to change long-term outcomes.

Conditions

The condition(s) this trial relates to.

Crohn disease indeterminate colitis inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.